Epidemiological Study on Gender Bias and Overtreatment in Primary Care Setting
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Any Condition
- Sponsor
- Universidad Miguel Hernandez de Elche
- Enrollment
- 1048000
- Locations
- 1
- Primary Endpoint
- Number of female patients who were recommended "do not do"
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The purpose of this study is to analyze if there are differences between men and women in the frequency of ignoring "Do not do" recommendations in primary care setting.
Detailed Description
First, using the Delphi technique, a consensus will be reached on those "Do Not Do" recommendations that should be included in the retrospective analysis study. The selection criteria for these recommendations will be if they are about pharmacological treatments, considered to persist in clinical practice in primary care, their relationship with factors associated with sex and gender, and if ignoring the "Do not do" recommendation could cause a serious adverse event. Second, a retrospective cohort study will be carried out including patients who attended primary care consultation in Alicante from 1st January 2022 to 31st December 2022. Data source will be the electronic record management system of the autonomous community of Valencia (named ABUCASIS), and they will be provided by the Ambulatory Assistance Information System (SIA-GAIA). Investigators will analyze the frequency of ignoring the "Do not do" recommendations previously selected by consensus by sex and age range.
Investigators
José Joaquín Mira
Professor
Universidad Miguel Hernandez de Elche
Eligibility Criteria
Inclusion Criteria
- •Attending primary care consultation from 1 January 2022 to 31 December
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Number of female patients who were recommended "do not do"
Time Frame: From 1st January 2022 to 31 December 2022
Number of female patients who were recommended "do not do"
Number of male patients who were recommended "do not do"
Time Frame: From 1st January 2022 to 31 December 2022
Number of male patients who were recommended "do not do"